Anti-tuberculosis treatment strategies and drug development: challenges and priorities
出版年份 2022 全文链接
标题
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-28
DOI
10.1038/s41579-022-00731-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery
- (2022) Madhukar Pai et al. NEW ENGLAND JOURNAL OF MEDICINE
- The physiology and genetics of bacterial responses to antibiotic combinations
- (2022) Roderich Roemhild et al. NATURE REVIEWS MICROBIOLOGY
- Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
- (2021) Thomas J Scriba et al. LANCET INFECTIOUS DISEASES
- Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model
- (2021) Jan Heyckendorf et al. EUROPEAN RESPIRATORY JOURNAL
- The knowns and unknowns of latent Mycobacterium tuberculosis infection
- (2021) W. Henry Boom et al. JOURNAL OF CLINICAL INVESTIGATION
- Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data
- (2021) Saskia E Mudde et al. JOURNAL OF INFECTIOUS DISEASES
- Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
- (2021) Yingda L. Xie et al. Science Translational Medicine
- Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis
- (2021) Poushali Chakraborty et al. Nature Communications
- Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols
- (2021) Ryan Dinkele et al. PLoS Pathogens
- Quantifying the rates of late reactivation tuberculosis: a systematic review
- (2021) Katie D Dale et al. LANCET INFECTIOUS DISEASES
- Diabetes y tuberculosis: una sindemia complicada por la COVID-19
- (2021) Violeta Antonio-Arques et al. MEDICINA CLINICA
- Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
- (2021) Susan E. Dorman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
- (2021) Nicholas D. Walter et al. Nature Communications
- A Ginger Root or Plum Model for the Tuberculosis “Granuloma”?
- (2021) Véronique Dartois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Micro–Computed Tomography Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in Three-dimensional Granuloma Morphology
- (2021) Gordon Wells et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 inhibitors TBA-7371, PBTZ169 and OPC-167832
- (2021) Gregory T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
- (2021) Barbara Bosch et al. CELL
- The Tuberculosis Drug Accelerator at year 10: what have we learned?
- (2021) Bree B. Aldridge et al. NATURE MEDICINE
- Optimizing antimicrobial use: challenges, advances and opportunities
- (2021) Timothy M. Rawson et al. NATURE REVIEWS MICROBIOLOGY
- Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia
- (2021) Juhyeon Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth of Mycobacterium tuberculosis at acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity
- (2021) Alexandre Gouzy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis
- (2021) Jonah Larkins-Ford et al. Cell Systems
- Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis
- (2021) Ray Y Chen et al. Lancet Microbe
- Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
- (2021) Summaya Perveen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Signature required: The transcriptional response to tuberculosis
- (2021) Clifton E. Barry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Latent Tuberculosis Infection
- (2021) Maunank Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance
- (2021) Mark Laws et al. TRENDS IN MICROBIOLOGY
- Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism
- (2021) Rachel P. J. Lai et al. mBio
- Antimicrobial Activity of Neutrophils Against Mycobacteria
- (2021) Heather A. Parker et al. Frontiers in Immunology
- Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
- (2020) Hanif Esmail et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial
- (2020) Greg J Fox et al. BMJ Open
- Advances in clinical trial design: Weaving tomorrow’s TB treatments
- (2020) Christian Lienhardt et al. PLOS MEDICINE
- Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters
- (2020) Jansy P. Sarathy et al. CLINICAL MICROBIOLOGY REVIEWS
- Granulocytes act as a niche for Mycobacterium tuberculosis growth
- (2020) Rustin R. Lovewell et al. Mucosal Immunology
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study
- (2020) Molly F Franke et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- New insights into the evasion of host innate immunity by Mycobacterium tuberculosis
- (2020) Qiyao Chai et al. Cellular & Molecular Immunology
- The potential impact of COVID-19-related disruption on tuberculosis burden
- (2020) C. Finn McQuaid et al. EUROPEAN RESPIRATORY JOURNAL
- Biology of antimicrobial resistance and approaches to combat it
- (2020) Sarah M. Schrader et al. Science Translational Medicine
- Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis
- (2020) Jacqueline P. Ernest et al. Annual Review of Pharmacology and Toxicology
- Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
- (2020) Francesca Boldrin et al. Frontiers in Microbiology
- Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB
- (2020) Elisa H. Ignatius et al. Current HIV/AIDS Reports
- The Pathogenesis of Tuberculosis–The Koch Phenomenon Reinstated
- (2020) Robert L. Hunter Pathogens
- Metabolic Fate of Human Immunoactive Sterols in Mycobacterium tuberculosis
- (2020) Tatsiana Varaksa et al. JOURNAL OF MOLECULAR BIOLOGY
- Drug combinations: a strategy to extend the life of antibiotics in the 21st century
- (2019) Mike Tyers et al. NATURE REVIEWS MICROBIOLOGY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Definitions and guidelines for research on antibiotic persistence
- (2019) Nathalie Q. Balaban et al. NATURE REVIEWS MICROBIOLOGY
- Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
- (2019) Natasha Strydom et al. PLOS MEDICINE
- Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs
- (2019) Daniel L. Clemens et al. PLoS One
- Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy
- (2019) Michelle M. Bellerose et al. mBio
- Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis
- (2019) Jae Jin Lee et al. Nature Communications
- Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
- (2019) Kelly E. Dooley et al. PLOS MEDICINE
- Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
- (2019) Geraint Davies et al. PLOS MEDICINE
- Heteroresistance: A cause of unexplained antibiotic treatment failure?
- (2019) Victor I. Band et al. PLoS Pathogens
- Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection
- (2019) Victor I. Band et al. Nature Microbiology
- Mycobacterium tuberculosis Metabolism
- (2019) Gabriel T. Mashabela et al. Microbiology Spectrum
- Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
- (2019) Kaican Zong et al. BMC MICROBIOLOGY
- Management of drug-resistant tuberculosis
- (2019) Christoph Lange et al. LANCET
- Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance
- (2019) Hassan Safi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modelling Treatment of Latent TB: Shortening the Leap of Faith?
- (2019) Andrew Vernon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress
- (2019) Giulia Manina et al. EMBO JOURNAL
- Therapeutic host-directed strategies to improve outcome in tuberculosis
- (2019) C. Young et al. Mucosal Immunology
- Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis
- (2019) Shuyi Ma et al. mBio
- Is Mycobacterium tuberculosis infection life long?
- (2019) Marcel A Behr et al. BMJ-British Medical Journal
- Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design
- (2018) Joel D. Ernst Cell Host & Microbe
- Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
- (2018) Paul K. Drain et al. CLINICAL MICROBIOLOGY REVIEWS
- Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions
- (2018) Nicolas A Menzies et al. LANCET INFECTIOUS DISEASES
- Ecology and evolution of Mycobacterium tuberculosis
- (2018) Sebastien Gagneux NATURE REVIEWS MICROBIOLOGY
- Toxin–antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosis
- (2018) Richard A Slayden et al. Pathogens and Disease
- The present state of the tuberculosis drug development pipeline
- (2018) M Daben J Libardo et al. CURRENT OPINION IN PHARMACOLOGY
- Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
- (2018) Dick Menzies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bacterial Factors That Predict Relapse after Tuberculosis Therapy
- (2018) Roberto Colangeli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation
- (2018) Swarnava Chaudhuri et al. eLife
- Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance
- (2018) Nathan D. Hicks et al. Nature Microbiology
- The End of the Binary Era: Revisiting the Spectrum of Tuberculosis
- (2018) Philana Ling Lin et al. JOURNAL OF IMMUNOLOGY
- Inhibiting the Evolution of Antibiotic Resistance
- (2018) Mark N. Ragheb et al. MOLECULAR CELL
- The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis
- (2018) Akul Singhania et al. NATURE IMMUNOLOGY
- A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
- (2018) Marjorie Z. Imperial et al. NATURE MEDICINE
- Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility
- (2018) Bai-Yu Lee et al. PLoS One
- Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis
- (2018) Kamila Romanowski et al. THORAX
- Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
- (2018) James A. Seddon et al. Trials
- Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription
- (2018) Jun-Hao Zhu et al. Nature Communications
- Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis
- (2018) Julie Early et al. ACS Infectious Diseases
- Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
- (2017) Dominik Zenner et al. EUROPEAN RESPIRATORY JOURNAL
- Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis
- (2017) Ruvandhi R. Nathavitharana et al. EUROPEAN RESPIRATORY JOURNAL
- The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition
- (2017) Gareth Prosser et al. MICROBES AND INFECTION
- Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity
- (2017) E. Hesper Rego et al. NATURE
- Why tolerance invites resistance
- (2017) Kim Lewis et al. SCIENCE
- Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery
- (2017) Divya Awasthi et al. TRENDS IN MICROBIOLOGY
- Host blood RNA signatures predict the outcome of tuberculosis treatment
- (2017) Ethan G. Thompson et al. TUBERCULOSIS
- Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
- (2017) Bibhuti B. Mishra et al. Nature Microbiology
- Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform
- (2017) Jeremy M. Rock et al. Nature Microbiology
- Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
- (2017) Murat Cokol et al. Science Advances
- Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis
- (2016) Melissa D. Chengalroyen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
- (2016) Obolbek Turapov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection
- (2016) Rustin R Lovewell et al. CURRENT OPINION IN MICROBIOLOGY
- Immune activation of the host cell induces drug tolerance inMycobacterium tuberculosisboth in vitro and in vivo
- (2016) Yancheng Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis
- (2016) Hannah Alsdurf et al. LANCET INFECTIOUS DISEASES
- Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
- (2016) Huiqing Zheng et al. Nature Chemical Biology
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
- (2016) Stephanus T Malherbe et al. NATURE MEDICINE
- Mechanisms of bacterial persistence during stress and antibiotic exposure
- (2016) Alexander Harms et al. SCIENCE
- Defining dormancy in mycobacterial disease
- (2016) S. Lipworth et al. TUBERCULOSIS
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Neutrophils in tuberculosis – first line of defence or booster of disease and targets for host directed therapy?
- (2016) Tobias Dallenga et al. Pathogens and Disease
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
- (2016) Eliza J. R. Peterson et al. Nature Microbiology
- A Sterilizing Tuberculosis Treatment Regimen Is Associated with Faster Clearance of Bacteria in Cavitary Lesions in Marmosets
- (2015) Laura E. Via et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improving the Tuberculosis Drug Development Pipeline
- (2015) Dimitrios Evangelopoulos et al. Chemical Biology & Drug Design
- Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial
- (2015) J. Torre-Cisneros et al. CLINICAL INFECTIOUS DISEASES
- New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics
- (2015) Thomas R. Hawn et al. IMMUNOLOGICAL REVIEWS
- Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
- (2015) Anne Lenaerts et al. IMMUNOLOGICAL REVIEWS
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
- (2015) Elsje Pienaar et al. JOURNAL OF THEORETICAL BIOLOGY
- WHO's new End TB Strategy
- (2015) Mukund Uplekar et al. LANCET
- Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection
- (2015) Jacqueline M. Kimmey et al. NATURE
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Treatment of Tuberculosis
- (2015) C. Robert Horsburgh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tuberculosis Treatment and Drug Regimens
- (2015) G. Sotgiu et al. Cold Spring Harbor Perspectives in Medicine
- Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
- (2014) Suresh B. Lakshminarayana et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
- (2014) Richard E Lee et al. NATURE MEDICINE
- How sisters grow apart: mycobacterial growth and division
- (2014) Karen J. Kieser et al. NATURE REVIEWS MICROBIOLOGY
- Expression of antimicrobial drug tolerance by attached communities ofMycobacterium tuberculosis
- (2014) David F. Ackart et al. Pathogens and Disease
- Identification of Novel Inhibitors of Nonreplicating Mycobacterium tuberculosis Using a Carbon Starvation Model
- (2013) Sarah Schmidt Grant et al. ACS Chemical Biology
- Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen
- (2013) Ian M. Bassett et al. JOURNAL OF MICROBIOLOGY
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis
- (2013) Crystal M. Darby et al. PLoS One
- Dynamic Persistence of Antibiotic-Stressed Mycobacteria
- (2013) Y. Wakamoto et al. SCIENCE
- Mycobacterium tuberculosis Responds to Chloride and pH as Synergistic Cues to the Immune Status of its Host Cell
- (2013) Shumin Tan et al. PLoS Pathogens
- Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
- (2012) Ming Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mixed-Strain Mycobacterium tuberculosis Infections and the Implications for Tuberculosis Treatment and Control
- (2012) T. Cohen et al. CLINICAL MICROBIOLOGY REVIEWS
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection and treatment of subclinical tuberculosis
- (2012) Brian D. Robertson et al. TUBERCULOSIS
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
- (2012) Scott G. Franzblau et al. TUBERCULOSIS
- Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
- (2011) B. B. Aldridge et al. SCIENCE
- Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
- (2011) Seung-Hun Baek et al. PLOS BIOLOGY
- Mycobacterium tuberculosis Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages
- (2011) Jaiyanth Daniel et al. PLoS Pathogens
- Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?
- (2010) Michael C. Chao et al. Annual Review of Microbiology
- Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
- (2010) Mi-Jeong Kim et al. EMBO Molecular Medicine
- High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery
- (2010) Thierry Christophe et al. Future Medicinal Chemistry
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Treatment of latent tuberculosis infection: An update
- (2010) Philip LOBUE et al. RESPIROLOGY
- Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
- (2009) Galina V. Mukamolova et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
- (2009) Seok-Yong Eum et al. CHEST
- Poverty and tuberculosis: is it truly a simple inverse linear correlation?
- (2009) B. J. Marais et al. EUROPEAN RESPIRATORY JOURNAL
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
- (2009) Clifton E. Barry et al. NATURE REVIEWS MICROBIOLOGY
- Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
- (2008) L. E. Via et al. INFECTION AND IMMUNITY
- Growth ofMycobacterium tuberculosisbiofilms containing free mycolic acids and harbouring drug-tolerant bacteria
- (2008) Anil K. Ojha et al. MOLECULAR MICROBIOLOGY
- Mycobacterial persistence requires the utilization of host cholesterol
- (2008) A. K. Pandey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum
- (2008) Natalie J Garton et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now